PHILADELPHIA, PA (MARKET WIRE) Dr. Maxine Gowen, Chief Executive Officer of Trevena, Inc., will be presenting on the topic of innovation in the pharmaceutical industry and the changing relationship between big pharma and biotech. Dr. Gowen remarked: "We are witnessing the adoption of the biotech culture by the world's leading pharmaceutical companies, in an effort to accelerate product pipelines in a capital efficient manner. However, the majority of new drug approvals continue to originate in small biotech companies. Given the current enormous financial stresses on the biotech industry can this situation be sustained?"